- Home
- ORMP vs STIM Comparison
ORMP vs STIM Comparison
Compare ORMP & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- STIM
- Stock Information
- Founded
- ORMP 2002
- STIM 2003
- Country
- ORMP United States
- STIM United States
- Employees
- ORMP N/A
- STIM N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- ORMP Health Care
- STIM Health Care
- Exchange
- ORMP Nasdaq
- STIM Nasdaq
- Market Cap
- ORMP N/A
- STIM 232.3M
- IPO Year
- ORMP N/A
- STIM 2018
- Fundamental
- Price
- ORMP $2.16
- STIM $3.37
- Analyst Decision
- ORMP Hold
- STIM Buy
- Analyst Count
- ORMP 1
- STIM 4
- Target Price
- ORMP N/A
- STIM $6.00
- AVG Volume (30 Days)
- ORMP 77.2K
- STIM 875.9K
- Earning Date
- ORMP 08-15-2025
- STIM 08-11-2025
- Dividend Yield
- ORMP N/A
- STIM N/A
- EPS Growth
- ORMP N/A
- STIM N/A
- EPS
- ORMP N/A
- STIM N/A
- Revenue
- ORMP $2,000,000.00
- STIM $89,448,000.00
- Revenue This Year
- ORMP N/A
- STIM $104.65
- Revenue Next Year
- ORMP N/A
- STIM $10.69
- P/E Ratio
- ORMP N/A
- STIM N/A
- Revenue Growth
- ORMP 196.74
- STIM 22.16
- 52 Week Low
- ORMP $1.82
- STIM $0.52
- 52 Week High
- ORMP $3.09
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- ORMP 48.10
- STIM 35.06
- Support Level
- ORMP $2.10
- STIM $3.11
- Resistance Level
- ORMP $2.25
- STIM $3.61
- Average True Range (ATR)
- ORMP 0.08
- STIM 0.21
- MACD
- ORMP 0.00
- STIM 0.01
- Stochastic Oscillator
- ORMP 52.63
- STIM 32.95
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.